ArticleEClinicalMedicine2024

GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 trial.

Myong Cheol Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.